HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study TJ Henrich, H Hatano, O Bacon, LE Hogan, R Rutishauser, A Hill, ... PLoS medicine 14 (11), e1002417, 2017 | 233 | 2017 |
Cerebrospinal fluid cytokine profiles predict risk of early mortality and immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis JN Jarvis, G Meintjes, T Bicanic, V Buffa, L Hogan, S Mo, G Tomlinson, ... PLoS pathogens 11 (4), e1004754, 2015 | 145 | 2015 |
Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30 LE Hogan, J Vasquez, KS Hobbs, E Hanhauser, B Aguilar-Rodriguez, ... PLoS pathogens 14 (2), e1006856, 2018 | 87 | 2018 |
Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30 LE Hogan, J Vasquez, KS Hobbs, E Hanhauser, B Aguilar-Rodriguez, ... PLoS pathogens 14 (2), e1006856, 2018 | 87 | 2018 |
Human immunodeficiency virus type 1 persistence following systemic chemotherapy for malignancy TJ Henrich, KS Hobbs, E Hanhauser, E Scully, LE Hogan, YP Robles, ... The Journal of infectious diseases 216 (2), 254-262, 2017 | 61 | 2017 |
High-throughput characterization of HIV-1 reservoir reactivation using a single-cell-in-droplet PCR assay RW Yucha, KS Hobbs, E Hanhauser, LE Hogan, W Nieves, MO Ozen, ... EBioMedicine 20, 217-229, 2017 | 57 | 2017 |
A humanized mouse-based HIV-1 viral outgrowth assay with higher sensitivity than in vitro qVOA in detecting latently infected cells from individuals on ART with undetectable … P Charlins, K Schmitt, L Remling-Mulder, LE Hogan, E Hanhauser, ... Virology 507, 135-139, 2017 | 45 | 2017 |
Modulation of Toll-like receptor activity by leukocyte Ig-like receptors and their effects during bacterial infection LE Pilsbury, RL Allen, M Vordermeier Mediators of inflammation 2010, 2010 | 38 | 2010 |
Elucidating the Burden of HIV in Tissues Using Multiplexed Immunofluorescence and In Situ Hybridization: Methods for the Single-Cell Phenotypic Characterization of Cells … JJ Vasquez, R Hussien, B Aguilar-Rodriguez, H Junger, D Dobi, ... Journal of Histochemistry & Cytochemistry 66 (6), 427-446, 2018 | 27 | 2018 |
Expression of the innate immune receptor LILRB5 on monocytes is associated with mycobacteria exposure LE Hogan, DC Jones, RL Allen Scientific reports 6, 21780, 2016 | 27 | 2016 |
Characterisation of bovine leukocyte Ig-like receptors L Hogan, S Bhuju, DC Jones, K Laing, J Trowsdale, P Butcher, M Singh, ... PloS one 7 (4), e34291, 2012 | 24 | 2012 |
Everolimus, an mTORC1/2 inhibitor, in ART‐suppressed individuals who received solid organ transplantation: A prospective study TJ Henrich, C Schreiner, C Cameron, LE Hogan, B Richardson, ... American Journal of Transplantation 21 (5), 1765-1779, 2021 | 21 | 2021 |
Evaluating a New Class of AKT/mTOR Activators for HIV Latency-Reversing Activity Ex Vivo and In Vivo A Gramatica, R Schwarzer, W Brantley, B Varco-Merth, HS Sperber, ... Journal of Virology 95 (8), e02393-20, 2021 | 21 | 2021 |
Non‐classical MHC class I molecules (MHC‐Ib) RL Allen, L Hogan eLS, 2013 | 19 | 2013 |
CD32-RNA Co-localizes with HIV-RNA in CD3+ Cells Found within Gut Tissues from Viremic and ART-Suppressed Individuals JJ Vásquez, BL Aguilar-Rodriguez, L Rodriguez, LE Hogan, M Somsouk, ... Pathogens and Immunity 4 (1), 147, 2019 | 15 | 2019 |
Transient loss of detectable HIV-1 RNA following brentuximab vedotin anti-CD30 therapy for Hodgkin lymphoma CC Wang, C Thanh, EA Gibson, M Ball-Burack, LE Hogan, B Descours, ... Blood Advances 2 (23), 3479-3482, 2018 | 15 | 2018 |
Very low levels of 25-hydroxyvitamin D are not associated with immunologic changes or clinical outcome in South African patients with HIV-associated cryptococcal meningitis JN Jarvis, T Bicanic, A Loyse, G Meintjes, L Hogan, CH Roberts, ... Clinical infectious diseases 59 (4), 493-500, 2014 | 14 | 2014 |
Rapid development of HIV elite control in a patient with acute infection D Morley, JS Lambert, LE Hogan, C De Gascun, N Redmond, ... BMC infectious diseases 19 (1), 1-6, 2019 | 13 | 2019 |
Cerebrospinal fluid soluble CD30 elevation despite suppressive antiretroviral therapy in individuals living with HIV-1 MJ Peluso, C Thanh, CA Prator, LE Hogan, VM Arechiga, S Stephenson, ... Journal of virus eradication 6 (1), 19-26, 2020 | 7 | 2020 |
Human Herpes Virus 8 in HIV-1 infected individuals receiving cancer chemotherapy and stem cell transplantation LE Hogan, E Hanhauser, KS Hobbs, CD Palmer, Y Robles, S Jost, ... PloS one 13 (5), e0197298, 2018 | 7 | 2018 |